Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
January 2010
Features
Q&A
An Interview Series with Members of the ASHP Expert Panel on Formulary Management
Part 3: Sabrina W. Cole, PharmD
In the third of a three-part series, topics such as drug approvals and shortages, therapeutic interchanges, and pharmacoeconomic assessments are discussed.
C. Lee Ventola, MS
Barriers to Implementing an Insulin Order Form In a Non-ICU Medical Unit
An order form for subcutaneous insulin was created to improve blood glucose control in hospitalized diabetic patients. Although use of the form by the staff was relatively low, teaching health care personnel about hyperglycemia and proper use of the form may help reduce complications after patient discharge.
Sally A. Arif, PharmD, BCPS; and Alisa K. Escaño, PharmD, BCPS, CDE
Alvimopan (Entereg) for the Management of Postoperative Ileus in Patients Undergoing Bowel Resection
Postoperative ileus is common after surgery, especially abdominal procedures. In clinical studies, alvimopan appeared to speed up gastrointestinal tract recovery, was associated with fewer adverse effects, and led to shorter hospital stays.
Michael Kraft, PharmD, BCNSP; Robert MacLaren, PharmD; Wei Du, PhD; and Gay Owens, PharmD
Meeting Highlights
American Heart Association, 2009 Scientific Sessions
Sessions covered the ARBITER 6-HALTS trial of ezetimibe (Zetia) and niacin (Niaspan); the HEAAL study of losartan (Cozaar); the relationships between statins, high-density lipoprotein-cholesterol (HDL-C) levels, and cardiovascular events; and the association of higher HDL-C levels with lower rates of breast cancer.
Walter Alexander
Pharmaceutical Approval Update
Topics include ecallantide (Kalbitor) for hereditary angioedema; a capsaicin 8% patch (Qutenza) for pain management; and romidepsin (Istodax) for patients with cutaneous T-cell lymphoma.
Marvin M. Goldenberg, PhD, RPh, MS
Departments
Editorial
Annual Evaluation
David B. Nash, MD, MBA, discusses his medication quality subcommittee’s annual assessment of its progress in promoting drug safety.
David B. Nash, MD, MBA
Medication Errors
Pumping up the Volume
Tips for Increasing Error Reporting
Matthew Grissinger, RPh, FASCP, provides suggestions to improve error-reporting systems.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Web of Confusion
FDA Tries to Clarify Rules for Internet Advertising
Stephen Barlas discusses the FDA’s attempt to clarify the rules on Internet advertising of drugs and medical devices.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
From Agriflu vaccine to Zyprexa, P&T presents the latest studies and information about FDA approvals, drug indications, product recalls, and industry updates.
Drug Forecast
Vigabatrin (Sabril), a Gamma-Aminobutyric Acid Transaminase Inhibitor for the Treatment of Two Catastrophic Seizure Disorders
Dr. Martin Cruz reviews vigabatrin (Sabril), a therapy for seizure disorders.
Martin P. Cruz, PharmD, CGP, BCPP
